Vero cytotoxin binding to polymorphonuclear leukocytes among households with children with hemolytic uremic syndrome

D M te Loo1, A E Heuvelink, E de Boer

  • 1Department of Pediatrics, University Hospital Nijmegen, 6500 HB Nijmegen, The Netherlands. M.teloo@ckslkn.azn.nl

Insights

Vero cytotoxin (VT) binding to polymorphonuclear leukocytes (PMNL) indicates infection in households with hemolytic uremic syndrome (HUS) patients. This finding suggests current diagnostic methods may underestimate the true prevalence of infection in these close contacts.

Area of Science:

  • Microbiology
  • Pediatric Nephrology
  • Infectious Diseases

Background:

  • Hemolytic uremic syndrome (HUS) is a primary cause of acute kidney injury in children.
  • Vero cytotoxin (VT)-producing Escherichia coli (VTEC) are a common cause of HUS.
  • VT has been observed to bind to polymorphonuclear leukocytes (PMNL) in HUS patients.

Purpose of the Study:

  • To determine if VT bound to PMNL can be detected in individuals within households of HUS patients.
  • To assess the prevalence of VTEC infection in household contacts of HUS patients.

Main Methods:

  • Detection of VT bound to circulating PMNL in household members.
  • Analysis of serum antibodies against E. coli O157.
  • Examination of fecal samples for VTEC presence.

Main Results:

  • VT bound to circulating PMNL was detected in 82% of household members.
  • Conventional stool and/or serum testing identified VTEC infection in only 21% of household members.
  • VT-PMNL binding is a more sensitive indicator of infection in household contacts.

Conclusions:

  • Current diagnostic methods for VTEC infection in household contacts of HUS patients are likely to underestimate the actual number of infected individuals.
  • VT-PMNL binding offers a promising alternative or supplementary diagnostic approach for identifying subclinical or asymptomatic infections.
  • Further research is warranted to validate VT-PMNL binding as a reliable diagnostic marker in HUS households.